IPO Boutique

Tesaro IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Tesaro, and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
TesaroTSRO -
NASDAQ
$12.00-$15.00 $13.50 $14.006.0 million6/28/2014
Citigroup, Morgan Stanley, Leerink Swann
Co-Manager(s):
BMO Capital Markets, Baird
Health Care
Filing(s):

Filed 2012-03-23



Tesaro Quote & Chart - Click for current quote - TSRO

About Tesaro (adapted from Tesaro prospectus):
They are an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients.

This description is adapted from Tesaro prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as Tesaro "TSRO" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved